Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

Bacteria Test Developer Reiterates Revenue Should Double in 2019

The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. In a May 31 research note, analyst Ram Selvaraju reported that H.C. Wainwright & Co. lowered its target price on T2 BioSystems Inc. (TTOO:NASDAQ) to $10 per sha...
Streetwise Reports | June 10, 2019 |

Antibody Developer Taken Out by Gilead at 'Hefty Premium'

The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. In a March 2 research note, BTIG analyst Robert Hazlett reported that Forty Seven Inc. (FTSV:NASDAQ) is being acquired by Gilead Sciences Inc. (GILD:NASDA...
Streetwise Reports | March 5, 2020 |

Lithium plant developer zeros in on Thunder Bay refinery site

Ian Ross, Northern Ontario BusinessAvalon Advanced Materials making purchase offer on city property to start refinery construction by 2023The developer of a much-anticipated lithium processing...
Research | July 12, 2022 |

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...
Streetwise Reports | May 27, 2019 |

Idaho Gold Developer Demonstrates Post-Tax 53% IRR

At the 2019 Beaver Creek Precious Metals Summit last week in Beaver Creek, Colorado, I had the opportunity to meet one-on-one with numerous junior mining management teams. Due to a rising gold price environment, the expectation and general mood among the management team...
Streetwise Reports | September 17, 2019 |

Improved Recovery Rate Spurs Target Price Increase on Gold Developer

The metallurgical result and its implications are addressed in a ROTH Capital Partners report. In an Aug. 14 research note, ROTH Capital Partners analyst Jake Sekelsy reported that the final results from the metallurgical work done at Vista Gold Corp.'s (VGZ:...
Streetwise Reports | August 20, 2019 |

U.S. Biotech Makes 'The Acquisition We Were Waiting For'

By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. In a March 4 BTIG research note, analyst Thomas Shrader reported that Biogen Inc. (BIIB:NASDAQ) entered into an agreement to acquire Nightstar Therapeutics Pl...
Streetwise Reports | March 7, 2019 |

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance

Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. Late yesterday afternoon, radiation oncology company Accuray Inc. (ARAY:NASDAQ) , which develops, manufactures and markets radiotherapy systems used in cancer trea...
Streetwise Reports | January 30, 2020 |

Consolidating one of the largest advanced-stage, undeveloped gold projects in Canada

First Mining Gold Corp. a Canadian gold developer focused on the development and permitting of the Springpole Gold Project in northwestern Ontario, one of the largest undeveloped gold projects in...
Jonathon Brown | August 2, 2022 |
1 2 3 4 5 6 7 8 9 10 ...